YZYBIO-B

2496
4.2005.00% ( +0.200 )
Delay Closed: Nov 16, 16:08:00

Profile

About

YZYBIO-B
YZYBIO-B
02496.HK

Wuhan YZY Biopharma Co., Ltd., a biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-associated complications, and age-related ophthalmologic diseases. It develops various product candidates for the treatment of malignant ascites, malignant pleural effusion, solid tumors, pancreatic cancer, hepatocellular carcinoma, and other advanced solid tumors; wAMD, DME, and other ocular neovascularization-related diseases; hemophilia; and inflammatory bowel diseases. The company was founded in 2010 and is headquartered in Wuhan, China.

Profile

Company Name
Wuhan YZY Biopharma Co., Ltd.
Market
SEHK
Founded
Industry
--
Fiscal Year End
December 31

Related Securities

Industry

Management